98 related articles for article (PubMed ID: 31118773)
1. Knockdown of CHPF suppresses cell progression of non-small-cell lung cancer.
Hou XM; Baloch Z; Zheng ZH; Zhang WH; Feng Y; Li DD; Wu XA; Yang SH
Cancer Manag Res; 2019; 11():3275-3283. PubMed ID: 31118773
[No Abstract] [Full Text] [Related]
2. Lentivirus‑mediated knockdown of chondroitin polymerizing factor inhibits glioma cell growth in vitro.
Fan YH; Xiao B; Lv SG; Ye MH; Zhu XG; Wu MJ
Oncol Rep; 2017 Aug; 38(2):1149-1155. PubMed ID: 28627702
[TBL] [Abstract][Full Text] [Related]
3. CHPF promotes lung adenocarcinoma proliferation and anti-apoptosis via the MAPK pathway.
Hou XM; Zhang T; Da Z; Wu XA
Pathol Res Pract; 2019 May; 215(5):988-994. PubMed ID: 30826152
[TBL] [Abstract][Full Text] [Related]
4. Expression of CHPF modulates cell proliferation and invasion in lung cancer.
Cao C; Liu Y; Wang Q; Zhao J; Shi M; Zheng J
Braz J Med Biol Res; 2020; 53(5):e9021. PubMed ID: 32348423
[TBL] [Abstract][Full Text] [Related]
5. Bioinformatics and Experimental Analysis of the Prognostic and Predictive Value of the CHPF Gene on Breast Cancer.
Li WW; Liu B; Dong SQ; He SQ; Liu YY; Wei SY; Mou JY; Zhang JX; Liu Z
Front Oncol; 2022; 12():856712. PubMed ID: 35372047
[TBL] [Abstract][Full Text] [Related]
6. KIAA1211 plays an oncogenic role in human non-small cell lung cancer.
Liu Z; Cao H; Shi Y; Yang R
J Cancer; 2019; 10(26):6747-6753. PubMed ID: 31777604
[TBL] [Abstract][Full Text] [Related]
7. Epididymal protein 3A is upregulated and promotes cell proliferation in non-small cell lung cancer.
Li G; Tong X; Pan L; Huang H; Ma H; Feng Y
Oncol Lett; 2020 Jun; 19(6):4024-4030. PubMed ID: 32391105
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
9. Lentivirus-mediated shRNA interference targeting cyclooxygenase-2 inhibits growth of human non-small cell lung cancer.
Li T; Lu J; Zhong Y
J BUON; 2013; 18(4):908-14. PubMed ID: 24344016
[TBL] [Abstract][Full Text] [Related]
10. Chondroitin polymerizing factor (CHPF) promotes development of malignant melanoma through regulation of CDK1.
Sun W; Zhao F; Xu Y; Huang K; Guo X; Zheng B; Liu X; Luo Z; Kong Y; Xu M; Schadendorf D; Chen Y
Cell Death Dis; 2020 Jul; 11(7):496. PubMed ID: 32612115
[TBL] [Abstract][Full Text] [Related]
11. Desmoglein-2 is overexpressed in non-small cell lung cancer tissues and its knockdown suppresses NSCLC growth by regulation of p27 and CDK2.
Cai F; Zhu Q; Miao Y; Shen S; Su X; Shi Y
J Cancer Res Clin Oncol; 2017 Jan; 143(1):59-69. PubMed ID: 27629878
[TBL] [Abstract][Full Text] [Related]
12. Lentivirus-mediated knockdown of TSP50 suppresses the growth of non-small cell lung cancer cells via G0/G1 phase arrest.
Qiao WL; Hu HY; Shi BW; Zang LJ; Jin W; Lin Q
Oncol Rep; 2016 Jun; 35(6):3409-18. PubMed ID: 27109614
[TBL] [Abstract][Full Text] [Related]
13. c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer.
Cui J; Mo J; Luo M; Yu Q; Zhou S; Li T; Zhang Y; Luo W
Int J Clin Exp Pathol; 2015; 8(10):12400-9. PubMed ID: 26722426
[TBL] [Abstract][Full Text] [Related]
14. Lentivirus-mediated knockdown of CTDP1 inhibits lung cancer cell growth in vitro.
Zhong R; Ge X; Chu T; Teng J; Yan B; Pei J; Jiang L; Zhong H; Han B
J Cancer Res Clin Oncol; 2016 Apr; 142(4):723-32. PubMed ID: 26590573
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of the M2 Isoform of Pyruvate Kinase (PKM2) with shRNA Enhances the Effect of Docetaxel in Human NSCLC Cell Lines In Vitro.
Yuan S; Qiao T; Zhuang X; Chen W; Xing N; Zhang Q
Yonsei Med J; 2016 Nov; 57(6):1312-23. PubMed ID: 27593857
[TBL] [Abstract][Full Text] [Related]
16. FOXD1 Promotes Cell Growth and Metastasis by Activation of Vimentin in NSCLC.
Li D; Fan S; Yu F; Zhu X; Song Y; Ye M; Fan L; Lv Z
Cell Physiol Biochem; 2018; 51(6):2716-2731. PubMed ID: 30562753
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of STAT3 potentiates growth, survival, and radioresistance of non-small-cell lung cancer (NSCLC) cells.
Yin ZJ; Jin FG; Liu TG; Fu EQ; Xie YH; Sun RL
J Surg Res; 2011 Dec; 171(2):675-83. PubMed ID: 20605584
[TBL] [Abstract][Full Text] [Related]
18. BATF acts as an oncogene in non-small cell lung cancer.
Feng Y; Pan L; Zhang B; Huang H; Ma H
Oncol Lett; 2020 Jan; 19(1):205-210. PubMed ID: 31897131
[TBL] [Abstract][Full Text] [Related]
19. Actin Filament-Associated Protein 1-Like 1 Mediates Proliferation and Survival in Non-Small Cell Lung Cancer Cells.
Wang M; Han X; Sun W; Li X; Jing G; Zhang X
Med Sci Monit; 2018 Jan; 24():215-224. PubMed ID: 29323101
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-361-3p suppresses tumor cell proliferation and metastasis by directly targeting SH2B1 in NSCLC.
Chen W; Wang J; Liu S; Wang S; Cheng Y; Zhou W; Duan C; Zhang C
J Exp Clin Cancer Res; 2016 May; 35():76. PubMed ID: 27164951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
